Treatment and Prognosis of Pediatric Medulloblastoma
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Pediatric Oncology".
Deadline for manuscript submissions: 25 November 2026
Special Issue Editor
Interests: medulloblastoma
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The fields of AI and Omics are currently revolutionizing precision medicine and have been successfully employed in several applications for cancers, allowing for unraveling disease complexity. These fields have recently been leveraged in pediatric medulloblastoma, showing promise in improving diagnostic and prognostic decisions. We invite researchers to submit their work in pediatric medulloblastoma research, which covers areas including radiomics, pathomics, radiogenomics, proteomics, and transcriptomics. These works should aim to offer workflows for reliable diagnosis, prognosis, and disease management in pediatric medulloblastoma. Specifically, AI researchers can submit their works on computational approaches using radiology and histology scans to enrich the current pediatric brain tumors’ classification schemes (classifying medulloblastoma from other posterior fossa tumors) or to improve the accuracy of the current risk-stratification approaches. Similarly, works that leverage genomics and radiomics (radiogenomics) in medulloblastoma are sought in this Special Issue, which provide improved tumor characterization that helps guide treatment decisions and improve patient outcomes. Other Omics approaches are welcomed in this Special Issue, including proteomics and transcriptomics.
Dr. Marwa Ismail
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pediatric medulloblastoma
- proteomics
- radiogenomics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
